A Danish RCT of the 10-week PEER (Paths to Everyday Life) group programme found meaningful gains in personal recovery, functioning and quality of life for adults with mental health difficulties.
[read the full story...]
A Danish RCT of the 10-week PEER (Paths to Everyday Life) group programme found meaningful gains in personal recovery, functioning and quality of life for adults with mental health difficulties.
[read the full story...]
A major new RCT of Structured Psychological Support finds brief therapy offers no meaningful benefit over usual care for people with personality disorders.
[read the full story...]
The EPISODE trial of psychedelic-assisted therapy for ‘treatment-resistant depression’ finds only modest effects, with a few clear responders, but lingering methodological questions.
[read the full story...]
A single dose of tocilizumab cleared inflammation in depressed patients, but did it ease their symptoms? A proof-of-concept RCT with cautious promise.
[read the full story...]
Up to 80% of people with personality disorder report neglect or abuse. So why aren’t we offering them trauma-focused therapy? A new trial has some answers.
[read the full story...]
A small proof-of-principle trial suggests MDMA-assisted therapy may be feasible and effective for depression, but open-label design and a highly pre-treated sample urge caution.
[read the full story...]
New evidence shows Melodies for Mums outperforms standard community activities in reducing postnatal depression, with sustained effects lasting six months after the singing ends.
[read the full story...]
New research suggests that weight gained in the first 12 weeks of antipsychotic treatment is the biggest driver of long-term obesity in psychosis.
[read the full story...]
Can training your brain’s reward circuits strengthen your immune response to vaccination? A new randomised controlled trial offers some fascinating early clues.
[read the full story...]
A new RCT tested text message CBT for generalised anxiety in young adults, with promising results. But is it ready for clinical practice?
[read the full story...]